Urolift before radiation to reduce urinary side effects
Part of Kidney & urinary clinical trials.
This study tests whether a procedure called Urolift (which gently opens the prostate to relieve urinary blockage) before radiation therapy (SBRT) can reduce urinary side effects for men who have both prostate cancer and an enlarged prostate. If you qualify, you might experience fewer urinary problems during and after your cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 99 years old.
- You must have prostate cancer that is being treated with a type of radiation therapy called SBRT.
- You must also have an enlarged prostate (BPH) that causes urinary symptoms.
- Your prostate must be a certain size (30–80 ml, about the size of a walnut to a small egg) and not have a middle lobe blocking the bladder.
- You should be healthy enough for a small procedure called Urolift, which opens the urethra without cutting.
- You cannot have had prior surgery on your lower urinary tract or have certain other bladder or prostate conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a newer ultrasound-guided method for a prostate lift procedure, which may improve urine flow and reduce symptoms in men with an enlarged prostate. It is an exploratory trial, meaning researchers are checking how well the new approach works compared to the usual method.
This trial tests a new device designed to treat symptoms of an enlarged prostate (BPH), such as frequent or difficult urination. It may help improve urine flow and reduce discomfort without traditional surgery.
This study compares two minimally invasive procedures that remove extra prostate tissue to help with urination problems. It may help if other treatments haven't worked.
This trial tests a device called Optilume BPH Catheter System for men with enlarged prostate that causes bothersome urinary symptoms. It aims to see how safe and effective it is in real-world use, offering a possible treatment for blocked urine flow without surgery.
This trial tests whether adding hormone therapy (ADT) to stereotactic body radiation therapy (SBRT) works better than SBRT alone for men with a specific type of prostate cancer called 'unfavorable intermediate risk.' The goal is to see if the combination helps control the cancer better.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.